Important information relating to Supply of Muse (Alprostadil) Urethral Sticks
To ensure on-going market availability of MUSE urethral sticks in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) have granted a batch specific variation to enable supply of packs with a defective anti-tamper seal.
Direct Healthcare Professional Communication
Click here to download letter sent to Healthcare Professionals
Mylan is unable to make any specific treatment recommendations to patients and recommend that patients speak to their healthcare provider to discuss treatment options according to their own health needs and their relevant clinical history.
Reporting Adverse Reactions/Events
Please continue to report suspected adverse reactions with any medicine or vaccine to the MHRA through the Yellow Card Scheme.
It is easiest and quickest to report ADRs online via the Yellow Card website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Alternatively, you can report via some clinical IT systems (EMIS/SystmOne/Vision/MiDatabank) or by calling the Commission on Human Medicines (CHM) free phone line: 0800-731-6789.
Adverse reactions/events should also be reported to MAH at e-mail address: email@example.com.
Muse® is indicated for the treatment of erectile dysfunction of primarily organic etiology.
MUSE® urethral stick (alprostadil)
MUSE® 500mg SmPC
MUSE® 500mg Patient Information Leaflet
MUSE® 1000mg SmPC
MUSE® 1000mg Patient Information Leaflet
Mylan Medical Information team can be contacted via the Mylan switch board on 01707 853000
DOP: October 2020